Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,440 | 31,750 | 40,130 | 40,517 | 10,407 |
| Marketable Securities | 0 | 0 | N/A | 0 | 502 |
| Receivables | 9,450 | 190 | N/A | 0 | 0 |
| Other current assets | 1,120 | 790 | 710 | 552 | 271 |
| TOTAL | $41,010 | $32,730 | $40,840 | $41,069 | $11,180 |
| Non-Current Assets | |||||
| PPE Net | 100 | 200 | 153 | 90 | 38 |
| Other Non-Current Assets | 1,530 | 80 | 0 | 10 | 9 |
| TOTAL | $1,630 | $280 | $153 | $100 | $47 |
| Total Assets | $42,660 | $33,010 | $41,150 | $41,169 | $11,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,170 | 0 | 5 | 134 |
| Accrued Expenses | 1,570 | 0 | N/A | 226 | 259 |
| Other current liabilities | 1,040 | 650 | N/A | 419 | 277 |
| TOTAL | $2,620 | $2,820 | $N/A | $650 | $670 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 950 | 0 | 0 | 0 | 0 |
| TOTAL | $8,920 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,550 | $2,820 | $950 | $650 | $670 |
| Shareholders' Equity | |||||
| Common Shares | 110 | 100 | 102 | 91 | 68 |
| Retained earnings | -47,410 | -36,960 | N/A | -17,358 | -11,400 |
| Other shareholders' equity | -3,150 | -1,660 | 40,098 | 112 | 25 |
| TOTAL | $31,100 | $30,190 | $40,200 | $40,519 | $10,557 |
| Total Liabilities And Equity | $42,650 | $33,010 | $41,150 | $41,169 | $11,227 |